TrialPanorama/TrialPanorama-database huggingface dataset:
Study 7711427 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7711427 — Surrogate Endpoint (SUR): Blood pressure
Study 31221941 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31221941 — Predictive Biomarker (PRD): CXCL16 mRNA
Genes: CXCL16; SCYB16; SRPSOX; UNQ2759/PRO6714
Study 28687477 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 28687477 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 21178123 — Surrogate Endpoint (SUR): Blood pressure
Study 27560168 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 27560168 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 27560168 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 27560168 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 27560168 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 27560168 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 27560168 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 23561603 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 11136293 — Predictive Biomarker (PRD): KSR1 mRNA
Genes: KSR1; KSR
Study 22414228 — Predictive Biomarker (PRD): KCNQ1 mRNA
Genes: KCNQ1; KCNA8; KCNA9; KVLQT1
Study 10894282 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29241383 — Surrogate Endpoint (SUR): Blood pressure
Study 21927922 — Surrogate Endpoint (SUR): Bone mineral density
Study 21029199 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 10968433 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1453199 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 4095819 — Surrogate Endpoint (SUR): Blood pressure
Study 4095819 — Surrogate Endpoint (SUR): Serum triglycerides
Study 19957087 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 2086017 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 28470952 — Surrogate Endpoint (SUR): Total kidney volume
Study 11558289 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 20823381 — Surrogate Endpoint (SUR): Blood pressure
Study 12970007 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 10381159 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6134671 — Surrogate Endpoint (SUR): Blood pressure
Study 20173678 — Surrogate Endpoint (SUR): Blood pressure
Study 20173678 — Surrogate Endpoint (SUR): Forced vital capacity
Study 10325782 — Surrogate Endpoint (SUR): Blood pressure
Study 29759944 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 8393895 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 23946472 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 18325461 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 11776204 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 11776204 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 11776204 — Surrogate Endpoint (SUR): Serum calcium
Study 1631944 — Surrogate Endpoint (SUR): Serum creatinine
Study 3159468 — Surrogate Endpoint (SUR): Blood pressure
Study 29446654 — Surrogate Endpoint (SUR): Serum uric acid
Study 18628697 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 12794414 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 28605472 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 6695766 — Surrogate Endpoint (SUR): Blood pressure
Study 19120715 — Surrogate Endpoint (SUR): Serum potassium
Study 19120715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19120715 — Surrogate Endpoint (SUR): Blood pressure
Study 16296712 — Surrogate Endpoint (SUR): Blood pressure
Study 16296712 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7211775 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30503386 — Predictive Biomarker (PRD): UGT2B17 mRNA
Genes: UGT2B17
Study 21724350 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 10204584 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8863869 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 28967554 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 6094076 — Surrogate Endpoint (SUR): Blood pressure
Study 6094076 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8890204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30618054 — Surrogate Endpoint (SUR): Serum uric acid
Study 27782851 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 28052588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15596567 — Surrogate Endpoint (SUR): Blood pressure
Study 15596567 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15596567 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25937373 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 25937373 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 25937373 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 21414125 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 11853284 — Safety Biomarker (SAF): Hyaluronic acid
Study 30088558 — Surrogate Endpoint (SUR): Blood pressure
Study 26881073 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 12699447 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 12699447 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 12699447 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9360565 — Surrogate Endpoint (SUR): Forced vital capacity
Study 21362527 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 14657064 — Surrogate Endpoint (SUR): Blood pressure
Study 8713784 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8713784 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 15954962 — Surrogate Endpoint (SUR): Blood pressure
Study 10608204 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 31269786 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24016566 — Safety Biomarker (SAF): miR-15a
Genes: MIR15A
Study 24016566 — Safety Biomarker (SAF): miR-16
Study 21632446 — Surrogate Endpoint (SUR): Serum calcium
Study 21632446 — Surrogate Endpoint (SUR): Blood pressure
Study 17062774 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17062774 — Surrogate Endpoint (SUR): Blood pressure
Study 2589355 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 11085201 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 11085201 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 11085201 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 21789517 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18161933 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 11938776 — Surrogate Endpoint (SUR): Blood pressure
Study 1285244 — Safety Biomarker (SAF): Interleukin 1
Study 1285244 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31254226 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 27075914 — Surrogate Endpoint (SUR): Blood pressure
Study 20347681 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 7539270 — Surrogate Endpoint (SUR): Serum creatinine
Study 26303700 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 26303700 — Predictive Biomarker (PRD): HTR2C mRNA
Genes: HTR2C; HTR1C
Study 26303700 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 26303700 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 26303700 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 24415640 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 24415640 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 24415640 — Predictive Biomarker (PRD): BIRC3 mRNA
Genes: BIRC3; API2; MIHC; RNF49
Study 26084292 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26084292 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26084292 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 26084292 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 24011142 — Surrogate Endpoint (SUR): Blood pressure
Study 21943032 — Predictive Biomarker (PRD): DCT mRNA
Genes: DCT; TYRP2
Study 21949699 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7800211 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 7800211 — Surrogate Endpoint (SUR): Serum calcium
Study 23644179 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23644179 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17218378 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11319712 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3508327 — Surrogate Endpoint (SUR): Serum creatinine
Study 28294471 — Surrogate Endpoint (SUR): Blood pressure
Study 18248107 — Surrogate Endpoint (SUR): Blood pressure
Study 14978133 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 10768243 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 22788576 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29330573 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 21523723 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study 19907042 — Surrogate Endpoint (SUR): Serum creatinine
Study 19907042 — Surrogate Endpoint (SUR): Blood pressure
Study 20197015 — Surrogate Endpoint (SUR): Blood pressure
Study 20197015 — Surrogate Endpoint (SUR): Serum creatinine
Study 16899775 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1291703 — Surrogate Endpoint (SUR): Blood pressure
Study 29167351 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 17318648 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 8061173 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 3288467 — Surrogate Endpoint (SUR): Blood pressure
Study 26169969 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 21240870 — Surrogate Endpoint (SUR): Blood pressure
Study 18048424 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16982453 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 9205026 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7525886 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2455150 — Surrogate Endpoint (SUR): Blood pressure
Study 19302707 — Safety Biomarker (SAF): Interleukin 12
Study 9579257 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 8683829 — Surrogate Endpoint (SUR): Blood pressure
Study 12471719 — Surrogate Endpoint (SUR): Blood pressure
Study 2617169 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 26597925 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24609919 — Surrogate Endpoint (SUR): Blood pressure
Study 19369056 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 19369056 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16306196 — Surrogate Endpoint (SUR): Serum creatinine
Study 16306196 — Surrogate Endpoint (SUR): Blood pressure
Study 12693434 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 10099034 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25701338 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 25701338 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 20617051 — Surrogate Endpoint (SUR): Blood pressure
Study 14620099 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 16129716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28404133 — Monitoring Biomarker (MOI): HBV DNA
Study 21631949 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 21631949 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 9148651 — Surrogate Endpoint (SUR): Hematologic response
Study 5309529 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 20805762 — Surrogate Endpoint (SUR): Bone mineral density
Study 18080339 — Monitoring Biomarker (MOI): HBV DNA
Study 11113407 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 29112459 — Predictive Biomarker (PRD): ENPP2 mRNA
Genes: ENPP2; ATX; PDNP2
Study 27761693 — Safety Biomarker (SAF): Reactive oxygen species
Study 11255809 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 9825577 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 29510398 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study 29510398 — Predictive Biomarker (PRD): NR3C1 mRNA
Genes: NR3C1; GRL
Study 22005660 — Surrogate Endpoint (SUR): Forced vital capacity
Study 10431945 — Surrogate Endpoint (SUR): Blood pressure
Study 7473523 — Surrogate Endpoint (SUR): Blood pressure
Study 7473523 — Surrogate Endpoint (SUR): Serum creatinine
Study 7394143 — Surrogate Endpoint (SUR): Blood pressure
Study 31479159 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study 24754313 — Predictive Biomarker (PRD): Hormone receptor
Study 24754313 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 24754313 — Surrogate Endpoint (SUR): Serum triglycerides
Study 15015443 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 15015443 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 15015443 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 15015443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 26044463 — Predictive Biomarker (PRD): FANCE mRNA
Genes: FANCE; FACE
Study 18007568 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 11755953 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 27716690 — Surrogate Endpoint (SUR): Blood pressure
Study 24249435 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24249435 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21083889 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24504788 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 28663317 — Predictive Biomarker (PRD): CLC mRNA
Genes: CLC; LGALS10; LGALS10A
Study 28663317 — Predictive Biomarker (PRD): CPA3 mRNA
Genes: CPA3
Study 28663317 — Predictive Biomarker (PRD): DNASE1L3 mRNA
Genes: DNASE1L3; DHP2; DNAS1L3
Study 28663317 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 28663317 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study 28663317 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 28663317 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 24103283 — Surrogate Endpoint (SUR): Blood pressure
Study 22052139 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 1990953 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 30905065 — Predictive Biomarker (PRD): LGALS3BP mRNA
Genes: LGALS3BP; M2BP
Study 24643911 — Surrogate Endpoint (SUR): Blood pressure
Study 19423132 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19423132 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2712275 — Surrogate Endpoint (SUR): Blood pressure
Study 11689731 — Surrogate Endpoint (SUR): Blood pressure
Study 25596150 — Surrogate Endpoint (SUR): Blood pressure
Study 22429128 — Surrogate Endpoint (SUR): Probing pocket depth
Study 17355168 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12213884 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 12213884 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 23294034 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18194386 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 1742750 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 21242674 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 21242674 — Surrogate Endpoint (SUR): Blood pressure
Study 21242674 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25691084 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 30895713 — Predictive Biomarker (PRD): MSI1 mRNA
Genes: MSI1
Study 30895713 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22829901 — Predictive Biomarker (PRD): BCAR1 mRNA
Genes: BCAR1; CAS; CASS1; CRKAS
Study 12076241 — Surrogate Endpoint (SUR): Bone mineral density
Study 31357534 — Predictive Biomarker (PRD): CYP27A1 mRNA
Genes: CYP27A1; CYP27
Study 31357534 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 12194936 — Predictive Biomarker (PRD): FMN1 mRNA
Genes: FMN1; FMN; LD
Study 8577657 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 30642911 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24603308 — Surrogate Endpoint (SUR): Serum creatinine
Study 24603308 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 19853193 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 3322763 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 12584827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12584827 — Safety Biomarker (SAF): Hyaluronic acid
Study 12584827 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 3510285 — Surrogate Endpoint (SUR): Blood pressure
Study 26629666 — Surrogate Endpoint (SUR): Blood pressure
Study 19134274 — Surrogate Endpoint (SUR): Blood pressure
Study 10616846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7250779 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 16735495 — Surrogate Endpoint (SUR): Bone mineral density
Study 10731187 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24060350 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 22038880 — Predictive Biomarker (PRD): SEMG1 mRNA
Genes: SEMG1; SEMG
Study 17975152 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 11973192 — Surrogate Endpoint (SUR): Blood pressure
Study 10392063 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 11317693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 11317693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 12685512 — Surrogate Endpoint (SUR): Blood pressure
Study 7343274 — Surrogate Endpoint (SUR): Blood pressure
Study 28351509 — Surrogate Endpoint (SUR): Bone mineral density
Study 22992964 — Surrogate Endpoint (SUR): Serum creatinine
Study 16401653 — Surrogate Endpoint (SUR): Blood pressure
Study 16401653 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 22905454 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17610348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17610348 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10200132 — Surrogate Endpoint (SUR): Blood pressure
Study 2099245 — Surrogate Endpoint (SUR): Blood pressure
Study 30744452 — Surrogate Endpoint (SUR): Blood pressure
Study 20002471 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9740930 — Surrogate Endpoint (SUR): Blood pressure
Study 23306586 — Surrogate Endpoint (SUR): Blood pressure
Study 18084791 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 10195518 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 10195518 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 10195518 — Surrogate Endpoint (SUR): Blood pressure
Study 21859820 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 19093729 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 19093729 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 18020969 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 18020969 — Surrogate Endpoint (SUR): Bone mineral density
Study 21471971 — Surrogate Endpoint (SUR): Blood pressure
Study 15820070 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 24829414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24829414 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 15972319 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15972319 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 15972319 — Surrogate Endpoint (SUR): Blood pressure
Study 31686981 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 31686981 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29888275 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22035805 — Predictive Biomarker (PRD): SCN9A mRNA
Genes: SCN9A; NENA
Study 20705157 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG